| Year |
Citation |
Score |
| 2020 |
Parahuleva MS, Worsch M, Euler G, Choukeir M, Mardini A, Parviz B, Kanse SM, Portig I, Khayrutdinov E, Schieffer B, Markus B. Factor VII Activating Protease Expression in Human Platelets and Accumulation in Symptomatic Carotid Plaque. Journal of the American Heart Association. 9: e016445. PMID 32856552 DOI: 10.1161/Jaha.120.016445 |
0.384 |
|
| 2020 |
Zuchtriegel G, Uhl B, Pick R, Ramsauer M, Dominik J, Mittmann LA, Canis M, Kanse S, Sperandio M, Krombach F, Reichel CA. Vitronectin stabilizes intravascular adhesion of neutrophils by coordinating beta2 integrin clustering. Haematologica. PMID 32703799 DOI: 10.3324/Haematol.2019.226241 |
0.393 |
|
| 2020 |
Byskov K, Etscheid M, Kanse SM. Cellular effects of factor VII activating protease (FSAP). Thrombosis Research. 188: 74-78. PMID 32087413 DOI: 10.1016/J.Thromres.2020.02.010 |
0.449 |
|
| 2020 |
Byskov K, Le Gall SM, Thiede B, Camerer E, Kanse SM. Protease activated receptors (PAR)-1 and -2 mediate cellular effects of factor VII activating protease (FSAP). Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 34: 1079-1090. PMID 31914657 DOI: 10.1096/Fj.201801986Rr |
0.439 |
|
| 2019 |
Nielsen NV, Roedel E, Manna D, Etscheid M, Morth JP, Kanse SM. Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP). Scientific Reports. 9: 18990. PMID 31831842 DOI: 10.1038/S41598-019-55531-X |
0.425 |
|
| 2019 |
Uslu Ö, Herold J, Kanse SM. VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization. Cells. 8. PMID 31698750 DOI: 10.3390/Cells8111396 |
0.38 |
|
| 2019 |
Rut W, Nielsen NV, Czarna J, Poreba M, Kanse SM, Drag M. Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma. Thrombosis Research. 182: 124-132. PMID 31479940 DOI: 10.1016/J.Thromres.2019.08.016 |
0.391 |
|
| 2019 |
Bohnert BN, Daiminger S, Wörn M, Sure F, Staudner T, Ilyaskin AV, Batbouta F, Janessa A, Schneider JC, Essigke D, Kanse S, Haerteis S, Korbmacher C, Artunc F. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. Acta Physiologica (Oxford, England). e13286. PMID 31006168 DOI: 10.1111/Apha.13286 |
0.317 |
|
| 2018 |
Subramaniam S, Kanse SM, Kothari H, Reinhardt C, Fletcher C. Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 29: 668-682. PMID 30439766 DOI: 10.1097/Mbc.0000000000000775 |
0.386 |
|
| 2018 |
Cole JW, Xu H, Ryan K, Jaworek T, Dueker N, McArdle P, Gaynor B, Cheng YC, O'Connell J, Bevan S, Malik R, Ahmed NU, Amouyel P, Anjum S, Bis JC, ... ... Kanse S, et al. Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke. Plos One. 13: e0206554. PMID 30383853 DOI: 10.1371/Journal.Pone.0206554 |
0.323 |
|
| 2018 |
Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM. Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP). Biochimica Et Biophysica Acta. PMID 30076961 DOI: 10.1016/J.Bbadis.2018.07.030 |
0.386 |
|
| 2018 |
Olsson M, Stanne TM, Pedersen A, Lorentzen E, Kara E, Martinez-Palacian A, Sand NPR, Jacobsen AF, Sandset PM, Sidelmann JJ, Engström G, Melander O, Kanse SM, Jern C. Genome-wide Analysis of Genetic Determinants of Circulating Factor VII-activating Protease (FSAP) Activity Journal of Thrombosis and Haemostasis. 16: 2024-2034. PMID 30070759 DOI: 10.1111/Jth.14258 |
0.37 |
|
| 2018 |
Praetner M, Zuchtriegel G, Holzer M, Uhl B, Schaubächer J, Mittmann L, Fabritius M, Fürst R, Zahler S, Funken D, Lerchenberger M, Khandoga A, Kanse S, Lauber K, Krombach F, et al. Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia-Reperfusion. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 29371242 DOI: 10.1161/Atvbaha.117.309760 |
0.301 |
|
| 2018 |
Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs). Thrombosis Research. 161: 36-42. PMID 29178989 DOI: 10.1016/J.Thromres.2017.11.012 |
0.387 |
|
| 2018 |
Cui X, Tjønnfjord GE, Kanse S, Iversen N, Dahm AE, Myklebust CF, Sun L, Jiang ZX, Ho M, Sandset PM. Tissue Factor Pathway Inhibitor Enhances Transendothelial Migration of Chronic Lymphocytic Leukemia Cells through Binding to Glypican-3 Blood. 132: 2452-2452. DOI: 10.1182/Blood-2018-99-111241 |
0.34 |
|
| 2017 |
Sperling C, Maitz MF, Grasso S, Werner C, Kanse SM. A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP). Acs Applied Materials & Interfaces. 9: 40107-40116. PMID 29091393 DOI: 10.1021/Acsami.7B14281 |
0.328 |
|
| 2017 |
Byskov K, Boettger T, Ruehle PF, Nielsen NV, Etscheid M, Kanse SM. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells. Atherosclerosis. 265: 133-139. PMID 28881271 DOI: 10.1016/J.Atherosclerosis.2017.08.029 |
0.409 |
|
| 2017 |
Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM. A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7. Thrombosis Research. 157: 111-116. PMID 28734156 DOI: 10.1016/J.Thromres.2017.07.013 |
0.357 |
|
| 2017 |
Kara E, Manna D, Løset GÅ, Schneider EL, Craik CS, Kanse S. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates. Thrombosis and Haemostasis. 117. PMID 28726978 DOI: 10.1160/Th17-02-0081 |
0.377 |
|
| 2017 |
Herold J, Nowak S, Kostin S, Daniel JM, Francke A, Subramaniam S, Braun-Dullaeus RC, Kanse SM. Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model. American Journal of Translational Research. 9: 3084-3095. PMID 28670395 |
0.312 |
|
| 2016 |
Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz AR, Assmann G, Rehberg M, Kanse SM, Nieswandt B, et al. Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function. Cell Reports. PMID 27524614 DOI: 10.1016/J.Celrep.2016.07.040 |
0.408 |
|
| 2016 |
Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM. Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes. The Journal of Biological Chemistry. 291: 21020-21028. PMID 27462075 DOI: 10.1074/Jbc.M116.744631 |
0.352 |
|
| 2016 |
Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, Herold J, Bauersachs J, Sedding DG, Kanse SM. Factor VII activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation. Journal of Thrombosis and Haemostasis : Jth. PMID 27431088 DOI: 10.1111/Jth.13417 |
0.447 |
|
| 2016 |
Bustamante A, Díaz-Fernández B, Giralt D, Boned S, Pagola J, Molina CA, García-Berrocoso T, Kanse SM, Montaner J. Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27073188 DOI: 10.1177/1747493016641949 |
0.346 |
|
| 2015 |
Reichel CA, Hessenauer ME, Pflieger K, Rehberg M, Kanse SM, Zahler S, Krombach F, Berghaus A, Strieth S. Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects. Plos One. 10: e0116883. PMID 25658820 DOI: 10.1371/Journal.Pone.0116883 |
0.373 |
|
| 2015 |
Joshi AU, Orset C, Engelhardt B, Baumgart-Vogt E, Gerriets T, Vivien D, Kanse SM. Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice. The European Journal of Neuroscience. 41: 965-75. PMID 25615590 DOI: 10.1111/Ejn.12830 |
0.669 |
|
| 2015 |
Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP). Thrombosis and Haemostasis. 113: 870-80. PMID 25427855 DOI: 10.1160/Th14-06-0519 |
0.375 |
|
| 2015 |
Martinez-Palacian A, Kanse S. P0401 : The serine protease FSAP (Factor VII Activating Protease) maintains the differentiated state of mouse hepatocytes Journal of Hepatology. 62. DOI: 10.1016/S0168-8278(15)30613-9 |
0.34 |
|
| 2014 |
Martinez-Palacian A, Kanse SM, Weiskirchen R. Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis. Proteomics. Clinical Applications. 8: 438-46. PMID 24497464 DOI: 10.1002/Prca.201300078 |
0.393 |
|
| 2014 |
Parahuleva MS, Kanse S, Hölschermann H, Zheleva K, Zandt D, Worsch M, Parviz B, Güttler N, Tillmanns H, Böning A, Erdogan A. Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study Journal of Thrombosis and Thrombolysis. 37: 317-325. PMID 23575879 DOI: 10.1007/S11239-013-0921-0 |
0.315 |
|
| 2013 |
Parahuleva MS, Maj R, Hölschermann H, Parviz B, Abdallah Y, Erdogan A, Tillmanns H, Kanse SM. Regulation of monocyte/macrophage function by factor VII activating protease (FSAP). Atherosclerosis. 230: 365-72. PMID 24075769 DOI: 10.1016/J.Atherosclerosis.2013.08.007 |
0.396 |
|
| 2013 |
Roedel EK, Schwarz E, Kanse SM. The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2). Journal of Biological Chemistry. 288: 7193-7203. PMID 23341458 DOI: 10.1074/Jbc.M112.433029 |
0.413 |
|
| 2013 |
Parahuleva MS, Ball N, Parviz B, Zandt D, Abdallah Y, Tillmanns H, Hoelschermann H, Kanse SM. Factor seven activating protease (FSAP) expression in human placenta and its role in trophoblast migration. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 167: 34-40. PMID 23218959 DOI: 10.1016/J.Ejogrb.2012.10.035 |
0.354 |
|
| 2013 |
Borkham-Kamphorst E, Zimmermann HW, Gassler N, Bissels U, Bosio A, Tacke F, Weiskirchen R, Kanse SM. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men. Journal of Hepatology. 58: 104-11. PMID 22989567 DOI: 10.1016/J.Jhep.2012.09.007 |
0.39 |
|
| 2012 |
Fraineau S, Monvoisin A, Clarhaut J, Talbot J, Simonneau C, Kanthou C, Kanse SM, Philippe M, Benzakour O. The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner. Blood. 120: 5073-83. PMID 23065156 DOI: 10.1182/Blood-2012-05-429183 |
0.378 |
|
| 2012 |
Reichel CA, Kanse SM, Krombach F. At the interface of fibrinolysis and inflammation: the role of urokinase-type plasminogen activator in the leukocyte extravasation cascade. Trends in Cardiovascular Medicine. 22: 192-6. PMID 23062972 DOI: 10.1016/J.Tcm.2012.07.019 |
0.373 |
|
| 2012 |
Etscheid M, Muhl L, Pons D, Jukema JW, König H, Kanse SM. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. Thrombosis Research. 130: 935-941. PMID 22906531 DOI: 10.1016/J.Thromres.2012.07.023 |
0.428 |
|
| 2012 |
Parahuleva MS, Langanke E, Hölschermann H, Parviz B, Abdallah Y, Stracke S, Tillmanns H, Kanse SM. Nicotine modulation of factor VII activating protease (FSAP) expression in human monocytes. Journal of Atherosclerosis and Thrombosis. 19: 962-9. PMID 22878700 DOI: 10.5551/Jat.9589 |
0.316 |
|
| 2012 |
Parahuleva MS, Hölschermann H, Zandt D, Pons-Kühnemann J, Parviz B, Weiskirchen R, Staubitz A, Tillmanns H, Erdogan A, Kanse SM. Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome. Circulation Journal : Official Journal of the Japanese Circulation Society. 76: 2653-61. PMID 22850287 DOI: 10.1253/Circj.Cj-11-1502 |
0.323 |
|
| 2012 |
Hanson E, Kanse SM, Joshi A, Jood K, Nilsson S, Blomstrand C, Jern C. Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke. Journal of Thrombosis and Haemostasis : Jth. 10: 848-56. PMID 22409238 DOI: 10.1111/J.1538-7836.2012.04692.X |
0.553 |
|
| 2012 |
Kanse SM, Gallenmueller A, Zeerleder S, Stephan F, Rannou O, Denk S, Etscheid M, Lochnit G, Krueger M, Huber-Lang M. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. Journal of Immunology (Baltimore, Md. : 1950). 188: 2858-65. PMID 22308306 DOI: 10.4049/Jimmunol.1103029 |
0.352 |
|
| 2012 |
Huber-Lang M, Denk S, Fulda S, Erler E, Kalbitz M, Weckbach S, Schneider EM, Weiss M, Kanse SM, Perl M. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro Molecular Immunology. 50: 60-65. PMID 22244896 DOI: 10.1016/J.Molimm.2011.12.005 |
0.318 |
|
| 2012 |
Kanse SM, Declerck PJ, Ruf W, Broze G, Etscheid M. Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 427-33. PMID 22116096 DOI: 10.1161/Atvbaha.111.238394 |
0.46 |
|
| 2011 |
Reichel CA, Uhl B, Lerchenberger M, Puhr-Westerheide D, Rehberg M, Liebl J, Khandoga A, Schmalix W, Zahler S, Deindl E, Lorenzl S, Declerck PJ, Kanse S, Krombach F. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation. 124: 1848-59. PMID 21969013 DOI: 10.1161/Circulationaha.110.017012 |
0.362 |
|
| 2011 |
Trompet S, Pons D, Kanse SM, de Craen AJ, Ikram MA, Verschuren JJ, Zwinderman AH, Doevendans PA, Tio RA, de Winter RJ, Slagboom PE, Westendorp RG, Jukema JW. Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality. Stroke Research and Treatment. 2011: 424759. PMID 21789270 DOI: 10.4061/2011/424759 |
0.329 |
|
| 2011 |
Kanse SM, Etscheid M. Factor VII activating protease. Hamostaseologie. 31: 174-178. PMID 21655671 DOI: 10.5482/Ha-1159 |
0.44 |
|
| 2010 |
Parahuleva MS, Hölschermann H, Erdogan A, Langanke E, Prickartz I, Parviz B, Weiskirchen R, Tillmanns H, Kanse SM. Factor seven ativating potease (FSAP) levels during normal pregnancy and in women using oral contraceptives. Thrombosis Research. 126: e36-40. PMID 20381831 DOI: 10.1016/J.Thromres.2010.03.003 |
0.31 |
|
| 2010 |
Baeten KM, Richard MC, Kanse SM, Mutch NJ, Degen JL, Booth NA. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: A mechanism for stimulation of fibrinolysis by platelets Journal of Thrombosis and Haemostasis. 8: 1313-1322. PMID 20180903 DOI: 10.1111/J.1538-7836.2010.03813.X |
0.372 |
|
| 2010 |
Kanse SM, Etscheid M. Factor VII activating protease (FSAP): caught in the cross‐fire between polycations and polyanions Journal of Thrombosis and Haemostasis. 8: 556-558. PMID 19995407 DOI: 10.1111/J.1538-7836.2009.03718.X |
0.328 |
|
| 2009 |
Muhl L, Galuska SP, Oörni K, Hernández-Ruiz L, Andrei-Selmer LC, Geyer R, Preissner KT, Ruiz FA, Kovanen PT, Kanse SM. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. The Febs Journal. 276: 4828-39. PMID 19664058 DOI: 10.1111/J.1742-4658.2009.07183.X |
0.451 |
|
| 2009 |
Muhl L, Hersemeyer K, Preissner KT, Weimer T, Kanse SM. Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions. Febs Letters. 583: 1994-8. PMID 19446554 DOI: 10.1016/J.Febslet.2009.05.012 |
0.44 |
|
| 2009 |
Wasmuth HE, Tag CG, Van de Leur E, Hellerbrand C, Mueller T, Berg T, Puhl G, Neuhaus P, Samuel D, Trautwein C, Kanse SM, Weiskirchen R. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. Hepatology (Baltimore, Md.). 49: 775-80. PMID 19105210 DOI: 10.1002/Hep.22707 |
0.353 |
|
| 2009 |
Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells. Liver International : Official Journal of the International Association For the Study of the Liver. 29: 686-91. PMID 19018983 DOI: 10.1111/J.1478-3231.2008.01897.X |
0.373 |
|
| 2009 |
Shibamiya A, Hersemeyer K, Schmidt Wöll T, Sedding D, Daniel JM, Bauer S, Koyama T, Preissner KT, Kanse SM. A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. Blood. 113: 714-22. PMID 18971420 DOI: 10.1182/Blood-2008-02-137901 |
0.367 |
|
| 2008 |
Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thrombosis and Haemostasis. 99: 286-9. PMID 18278176 DOI: 10.1160/Th07-10-0640 |
0.476 |
|
| 2008 |
Parahuleva MS, Kanse SM, Parviz B, Barth A, Tillmanns H, Bohle RM, Sedding DG, Hölschermann H. Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques. Atherosclerosis. 196: 164-71. PMID 17482622 DOI: 10.1016/J.Atherosclerosis.2007.03.042 |
0.373 |
|
| 2007 |
Petzinger J, Saltel F, Hersemeyer K, Daniel JM, Preissner KT, Wehrle-Haller B, Kanse SM. Urokinase receptor (CD87) clustering in detergent-insoluble adhesion patches leads to cell adhesion independently of integrins. Cell Communication & Adhesion. 14: 137-55. PMID 17957530 DOI: 10.1080/15419060701557487 |
0.362 |
|
| 2007 |
Tag CG, Mengsteab S, Weiskirchen R, Kanse SM. Rapid genotyping of the G534E polymorphism (Marburg I) of the gene encoding the factor VII-activating protease (FSAP) by LightCycler PCR. Clinical Biochemistry. 40: 1063-4. PMID 17574227 DOI: 10.1016/J.Clinbiochem.2007.05.007 |
0.315 |
|
| 2007 |
Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. The Journal of Biological Chemistry. 282: 21671-82. PMID 17540775 DOI: 10.1074/Jbc.M610748200 |
0.404 |
|
| 2007 |
Shibamiya A, Muhl L, Tannert-Otto S, Preissner KT, Kanse SM. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation. The Biochemical Journal. 404: 45-50. PMID 17300216 DOI: 10.1042/Bj20070166 |
0.379 |
|
| 2007 |
Muhl L, Nykjaer A, Wygrecka M, Monard D, Preissner KT, Kanse SM. Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP. The Biochemical Journal. 404: 191-6. PMID 17298300 DOI: 10.1042/Bj20061630 |
0.446 |
|
| 2006 |
Sedding D, Daniel JM, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus RC, Tillmanns H, Weimer T, Preissner KT, Kanse SM. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. The Journal of Experimental Medicine. 203: 2801-7. PMID 17145954 DOI: 10.1084/Jem.20052546 |
0.415 |
|
| 2006 |
Altincicek B, Shibamiya A, Trusheim H, Tzima E, Niepmann M, Linder D, Preissner KT, Kanse SM. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. The Biochemical Journal. 394: 687-92. PMID 16332249 DOI: 10.1042/Bj20051563 |
0.331 |
|
| 2006 |
Shibamiya A, Altincicek B, Tannert-Otto S, Preissner KT, Kanse SM. Extracellular RNA potentiates Factor VII Activating Protease (FSAP)-mediated inhibition of vascular smooth muscle cell proliferation induced by Platelet-Derived Growth Factor-BB (PDGF-BB) Vascular Pharmacology. 45. DOI: 10.1016/J.Vph.2006.08.385 |
0.399 |
|
| 2006 |
Muhl L, Preissner KT, Kanse SM. Factor VII activating protease (FSAP): interaction with inhibitors and low density lipoprotein receptor related protein (LRP) Vascular Pharmacology. 45. DOI: 10.1016/J.Vph.2006.08.356 |
0.362 |
|
| 2006 |
Sedding D, Kanse SM, Preissner KT, Daniel J-, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus R, Tillmanns H. Factor VII activating protease (FSAP) inhibits neointima formation and the G511E polymorphism is associated with atherosclerosis due to a loss of this activity Vascular Pharmacology. 45. DOI: 10.1016/J.Vph.2006.08.272 |
0.404 |
|
| 2006 |
Kanse SM, Celik I, Linn T, Sürücü O, Matz R, Henning S, Dietz C, Uslu Ö, Weimer T, Preissner KT. Factor VII activating protease (FSAP): A plasma protein that inhibits angiogenesis in vivo Vascular Pharmacology. 45. DOI: 10.1016/J.Vph.2006.08.182 |
0.407 |
|
| 2005 |
Kanse SM, Liang O, Schubert U, Haas H, Preissner KT, Doenhoff MJ, Dennis RD. Characterisation and partial purification of Schistosoma mansoni egg-derived pro-angiogenic factor. Molecular and Biochemical Parasitology. 144: 76-85. PMID 16169609 DOI: 10.1016/J.Molbiopara.2005.08.001 |
0.367 |
|
| 2004 |
Kanse SM, Matz RL, Preissner KT, Peter K. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18). Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 2251-6. PMID 15458976 DOI: 10.1161/01.Atv.0000146529.68729.8B |
0.375 |
|
| 2004 |
Kanse SM, Chavakis T, Kuo A, Bdeir K, Cines DB, Preissner KT. Variability in the expression of urokinase receptor (CD87) mutants on cells: relevance to cell adhesion. Cell Biochemistry and Function. 22: 257-64. PMID 15248186 DOI: 10.1002/Cbf.1098 |
0.35 |
|
| 2004 |
Kannemeier C, Al-Fakhri N, Preissner KT, Kanse SM. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 728-30. PMID 14977886 DOI: 10.1096/Fj.03-0898Fje |
0.45 |
|
| 2004 |
Kanse SM, Chavakis T, Al-Fakhri N, Hersemeyer K, Monard D, Preissner KT. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1. Journal of Cell Science. 117: 477-85. PMID 14679304 DOI: 10.1242/Jcs.00861 |
0.44 |
|
| 2003 |
Rhee JS, Santoso S, Herrmann M, Bierhaus A, Kanse SM, May AE, Nawroth PP, Colman RW, Preissner KT, Chavakis T. New aspects of integrin-mediated leukocyte adhesion in inflammation: regulation by haemostatic factors and bacterial products. Current Molecular Medicine. 3: 387-92. PMID 12776993 DOI: 10.2174/1566524033479753 |
0.4 |
|
| 2003 |
Deindl E, Ziegelhöffer T, Kanse SM, Fernandez B, Neubauer E, Carmeliet P, Preissner KT, Schaper W. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. The Faseb Journal. 17: 1174-1176. PMID 12692088 DOI: 10.1096/Fj.02-0800Fje |
0.344 |
|
| 2002 |
May AE, Schmidt R, Kanse SM, Chavakis T, Stephens RW, Schömig A, Preissner KT, Neumann FJ. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction Blood. 100: 3611-3617. PMID 12393744 DOI: 10.1182/Blood-2002-03-0778 |
0.385 |
|
| 2002 |
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nature Medicine. 8: 687-93. PMID 12091905 DOI: 10.1038/Nm728 |
0.362 |
|
| 2002 |
Schoppet M, Chavakis T, Al-Fakhri N, Kanse SM, Preissner KT. Molecular interactions and functional interference between vitronectin and transforming growth factor-beta. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 37-46. PMID 11796824 DOI: 10.1038/Labinvest.3780393 |
0.31 |
|
| 2001 |
Chavakis T, Kanse SM, Pixley RA, May AE, Isordia-Salas I, Colman RW, Preissner KT. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen Faseb Journal. 15: 2365-2376. PMID 11689462 DOI: 10.1096/Fj.01-0201Com |
0.309 |
|
| 2001 |
Liang OD, Chavakis T, Kanse SM, Preissner KT. Ligand Binding Regions in the Receptor for Urokinase-type Plasminogen Activator STRUCTURAL REQUIREMENTS FOR A MULTIDOMAIN BINDING REGION AND RECEPTOR-RECEPTOR INTERACTION Journal of Biological Chemistry. 276: 28946-28953. PMID 11501527 DOI: 10.1074/Jbc.M011347200 |
0.35 |
|
| 2001 |
Chavakis T, Willuweit AK, Lupu F, Preissner KT, Kanse SM. Release of soluble urokinase receptor from vascular cells. Thrombosis and Haemostasis. 86: 686-693. DOI: 10.1055/S-0037-1616105 |
0.393 |
|
| 2001 |
Chavakis T, Kanse SM, May AE, Preissner KT. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochemical Society Transactions. 30: 168-173. DOI: 10.1042/Bst0300168 |
0.467 |
|
| 2001 |
Ziegelhoeffer T, Deindl E, Scholz D, Kanse S, Carmeliet P, Schaper W. Urokinase but not tissue-type plasminogen activator is involved in collateral artery growth Journal of Molecular and Cellular Cardiology. 33. DOI: 10.1016/S0022-2828(01)90553-X |
0.319 |
|
| 2000 |
Preissner KT, Kanse SM, May AE. Urokinase receptor: A molecular organizer in cellular communication Current Opinion in Cell Biology. 12: 621-628. PMID 10978899 DOI: 10.1016/S0955-0674(00)00141-1 |
0.374 |
|
| 2000 |
Preissner KT, Nawroth PP, Kanse SM. Vascular protease receptors: integrating haemostasis and endothelial cell functions The Journal of Pathology. 190: 360-372. PMID 10685070 DOI: 10.1002/(Sici)1096-9896(200002)190:3<360::Aid-Path574>3.0.Co;2-8 |
0.403 |
|
| 2000 |
Chavakis T, Kanse SM, Lupu F, Hammes H, Müller-Esterl W, Pixley RA, Colman RW, Preissner KT. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood. 96: 514-522. DOI: 10.1182/Blood.V96.2.514.014K45_514_522 |
0.368 |
|
| 1999 |
Preissner KT, Kanse SM, Chavakis T, May AE. The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: Implications for cardiovascular function Basic Research in Cardiology. 94: 315-321. PMID 10543306 DOI: 10.1007/S003950050157 |
0.391 |
|
| 1999 |
Wohn K, Schmidt T, Kanse SM, Yutzy B, Germer M, Morgenstern E, Preissner KT. The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion. British Journal of Haematology. 104: 901-908. PMID 10192457 DOI: 10.1046/J.1365-2141.1999.01242.X |
0.328 |
|
| 1999 |
Klouche M, May AE, Hemmes M, Meßner M, Kanse SM, Preissner KT, Bhakdi S. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 784-793. PMID 10073987 DOI: 10.1161/01.Atv.19.3.784 |
0.318 |
|
| 1999 |
Chavakis T, May AE, Preissner KT, Kanse SM. Molecular Mechanisms of Zinc-Dependent Leukocyte Adhesion Involving the Urokinase Receptor and β2-Integrins Blood. 93: 2976-2983. DOI: 10.1182/Blood.V93.9.2976.409K21_2976_2983 |
0.406 |
|
| 1998 |
May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo Journal of Experimental Medicine. 188: 1029-1037. PMID 9743521 DOI: 10.1084/Jem.188.6.1029 |
0.359 |
|
| 1998 |
Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 2848-54. PMID 9409265 DOI: 10.1161/01.ATV.17.11.2848 |
0.355 |
|
| 1998 |
Chavakis T, Kanse SM, Yutzy B, Lijnen HR, Preissner KT. Vitronectin Concentrates Proteolytic Activity on the Cell Surface and Extracellular Matrix by Trapping Soluble Urokinase Receptor-Urokinase Complexes Blood. 91: 2305-2312. DOI: 10.1182/Blood.V91.7.2305.2305_2305_2312 |
0.421 |
|
| 1997 |
Ständker L, Schrader M, Kanse SM, Jürgens M, Forssmann WG, Preissner KT. Isolation and characterization of the circulating form of human endostatin. Febs Letters. 420: 129-33. PMID 9459295 DOI: 10.1016/S0014-5793(97)01503-2 |
0.342 |
|
| 1997 |
Kjøller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA. Plasminogen activator inhibitor-1 represses integrin-and vitronectin- mediated cell migration independently of its function as an inhibitor of plasminogen activation Experimental Cell Research. 232: 420-429. PMID 9168821 DOI: 10.1006/Excr.1997.3540 |
0.424 |
|
| 1997 |
Wohn K, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage Thrombosis and Haemostasis. 77: 540-547. DOI: 10.1055/S-0038-1656003 |
0.343 |
|
| 1996 |
Kanthou C, Kanse SM, Kakkar VV, Benzakour O. Involvement of Pertussis toxin-sensitive and -insensitive G proteins in α-thrombin signalling on cultured human vascular smooth muscle cells Cellular Signalling. 8: 59-66. PMID 8777142 DOI: 10.1016/0898-6568(95)02018-7 |
0.37 |
|
| 1996 |
Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT. The Urokinase Receptor Is a Major Vitronectin-Binding Protein on Endothelial Cells Experimental Cell Research. 224: 344-353. PMID 8612711 DOI: 10.1006/Excr.1996.0144 |
0.416 |
|
| 1996 |
Benzakour O, Kanthou C, Kanse SM, Scully MF, Kakkar VV, Cooper DN. Evidence for cultured human vascular smooth muscle cell heterogeneity: isolation of clonal cells and study of their growth characteristics Thrombosis and Haemostasis. 75: 854-858. DOI: 10.1055/S-0038-1650379 |
0.328 |
|
| Show low-probability matches. |